Retinopathy of Prematurity

• 

  Subject Areas on Research

  • A Comparison of Strategies for Retinopathy of Prematurity Detection. 
  • A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. 
  • A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. 
  • A hybrid method in combining treatment effects from matched and unmatched studies. 
  • A numeric index based on spatial frequency for the tortuosity of retinal vessels and its application to plus disease in retinopathy of prematurity. 
  • A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity. 
  • A pilot study using ROPtool to measure retinal vascular dilation. 
  • A potential biomarker in the cord blood of preterm infants who develop retinopathy of prematurity. 
  • Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. 
  • Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. 
  • An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials. 
  • Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. 
  • Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age. 
  • Bevacizumab for retinopathy of prematurity. 
  • Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. 
  • Clinical course and systemic correlates of retinopathy of prematurity in quintuplets. 
  • Combining ROPtool measurements of vascular tortuosity and width to quantify plus disease in retinopathy of prematurity. 
  • Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images. 
  • Computer-assisted measurement of retinal vascular width and tortuosity in retinopathy of prematurity. 
  • Computer-assisted quantification of pre-plus and plus disease in images obtained using Pictor versus video indirect ophthalmoscopy: a pilot study. 
  • Computer-assisted quantification of vascular tortuosity in retinopathy of prematurity (an American Ophthalmological Society thesis). 
  • Current and future trends in treatment of severe retinopathy of prematurity. 
  • Delay in retinal photoreceptor development in very preterm compared to term infants. 
  • Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. 
  • Differentials and approach to leukocoria. 
  • Does carbon dioxide play a role in retrolental fibroplasia? 
  • Early CPAP versus surfactant in extremely preterm infants. 
  • Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. 
  • Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. 
  • Effect of cyclooxygenase inhibition on retinal and choroidal blood flow during hypercarbia in newborn piglets. 
  • Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. 
  • Emerging evidence concerning systemic safety of anti-VEGF agents--should ophthalmologists be concerned? 
  • Evaluation of Screening for Retinopathy of Prematurity by ROPtool or a Lay Reader. 
  • Evaluation of an indirect ophthalmoscopy digital photographic system as a retinopathy of prematurity screening tool. 
  • Evaluation of optic nerve development in preterm and term infants using handheld spectral-domain optical coherence tomography. 
  • Evaluation of the accuracy of grading indirect ophthalmoscopy video images for retinopathy of prematurity screening. 
  • Evolution of plus disease in retinopathy of prematurity: quantification by ROPtool. 
  • Facilitated Versus Self-guided Training of Non-ophthalmologists for Grading Pre-plus and Plus Disease Using Fundus Images for Retinopathy of Prematurity Screening. 
  • Fellowship training in retinopathy of prematurity. 
  • Foveal avascular zone and foveal pit formation after preterm birth. 
  • Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. 
  • Genomics in the neonatal nursery: Focus on ROP. 
  • HANDHELD SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING THROUGH THE UNDILATED PUPIL IN INFANTS BORN PRETERM OR WITH HYPOXIC INJURY OR HYDROCEPHALUS. 
  • Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. 
  • History of oxygen therapy and retrolental fibroplasia. Prepared by the American Academy of Pediatrics, Committee on Fetus and Newborn with the collaboration of special consultants. 
  • Hyperoxemic retinal necrosis in the premature neonate. 
  • Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. 
  • Incidence of retinopathy of prematurity in the United States: 1997 through 2005. 
  • Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. 
  • Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. 
  • Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. 
  • Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants. 
  • Introduction. 
  • Long-term visual results of children after initially successful vitrectomy for stage V retinopathy of prematurity. 
  • Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. 
  • Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. 
  • Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. 
  • Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services. 
  • Neurodevelopmental outcome of infants with unilateral or bilateral periventricular hemorrhagic infarction. 
  • Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. 
  • Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. 
  • OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEA IN CHILDREN BORN PRETERM. 
  • Observer sensitivity to retinal vessel diameter and tortuosity in retinopathy of prematurity: a model system. 
  • One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. 
  • Optical coherence tomography in retinopathy of prematurity: looking beyond the vessels. 
  • Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. 
  • Oxygen saturation levels and retinopathy of prematurity--are we on target? 
  • Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. 
  • Parents' Knowledge and Education of Retinopathy of Prematurity in Four California Neonatal Intensive Care Units. 
  • Phthisis bulbi after lensectomy in retinopathy of prematurity eyes previously treated with laser photocoagulation. 
  • Plus disease. 
  • Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery. 
  • Posterior Pole Vascular Changes Before Treatment of Retinopathy of Prematurity. 
  • Predicting the need for laser treatment in retinopathy of prematurity using computer-assisted quantitative vascular analysis. 
  • Predictive value of pre-plus disease in retinopathy of prematurity. 
  • Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia. 
  • Preterm infants born at less than 31 weeks' gestation have improved growth in cycled light compared with continuous near darkness. 
  • Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. 
  • ROPtool analysis of images acquired using a noncontact handheld fundus camera (Pictor)--a pilot study. 
  • Real-World Simulation of an Alternative Retinopathy of Prematurity Screening System in Thailand: A Pilot Study. 
  • Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. 
  • Refractive errors and strabismus in premature Asian infants with and without retinopathy of prematurity. 
  • Retinal imaging in premature infants using the Pictor noncontact digital camera. 
  • Retinal neovascular markers in retinopathy of prematurity: aetiological implications. 
  • Retinal vessels and retinopathy of prematurity. 
  • Retinopathy of Prematurity: Anti-VEGF treatment for ROP: which drug and what dose? 
  • Retinopathy of prematurity and brain damage in the very preterm newborn. 
  • Retinopathy of prematurity care: patterns of care and workforce analysis. 
  • Retinopathy of prematurity in the United States. 
  • Retinopathy of prematurity risk prediction for infants with birth weight less than 1251 grams. 
  • Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. 
  • Retinopathy of prematurity. Diagnosis, severity, and natural history. 
  • Retinopathy of prematurity: a new look at an old disease. 
  • Retinopathy of prematurity: late complications in the baby boomer generation (1946-1964). 
  • Retinopathy of prematurity: the disease process, classifications, screening, treatment, and outcomes. 
  • Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. 
  • Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants. 
  • Sample size for comparing correlated concordance rates. 
  • Screening examination of premature infants for retinopathy of prematurity. 
  • Screening examination of premature infants for retinopathy of prematurity. 
  • Significance of isolated neovascular tufts ("popcorn") in retinopathy of prematurity. 
  • Sildenafil and retinopathy of prematurity risk in very low birth weight infants. 
  • Single grading vs double grading with adjudication in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. 
  • Sixty golden minutes. 
  • Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. 
  • Speculation on carbon dioxide and retrolental fibroplasia. 
  • Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 12-month experience with telemedicine screening. 
  • Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 18-month experience with telemedicine screening. 
  • Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening. 
  • Stanford University network for diagnosis of retinopathy of prematurity (SUNDROP): 36-month experience with telemedicine screening. 
  • Systematic review of digital imaging screening strategies for retinopathy of prematurity. 
  • Target ranges of oxygen saturation in extremely preterm infants. 
  • The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. 
  • The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. 
  • Three-dimensional assessment of vascular and perivascular characteristics in subjects with retinopathy of prematurity. 
  • Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity. 
  • Timely implementation of a retinopathy of prematurity telemedicine system. 
  • Tortuosity of arterioles and venules in quantifying plus disease. 
  • Transcutaneous oxygen monitoring and retinopathy of prematurity. 
  • Treatment of retinopathy of prematurity with argon laser photocoagulation. 
  • Treatment outcome in fellow eyes after laser photocoagulation for retinopathy of prematurity. 
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. 
  • Using video indirect ophthalmoscopy to demonstrate retinopathy of prematurity findings. 
  • Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. 
  • Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. 
  • Vascular dilation and tortuosity in plus disease. 
• 

  Keywords of People

  • Farsiu, Sina, Paul Ruffin Scarborough Associate Professor of Engineering, Electrical and Computer Engineering
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
  • Toth, Cynthia Ann, Joseph A.C. Wadsworth Professor of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery